Molecular Serum Markers of Liver Fibrosis
Fibrosis is a hallmark histologic event of chronic liver diseases and is characterized by the excessive accumulation and reorganization of the extracellular matrix (ECM). The gold standard for assessment of fibrosis is liver biopsy. As this procedure has various limitations, including risk of patien...
Main Authors: | Tianhui Liu, Xiaoming Wang, Morten A. Karsdal, Diana J. Leeming, Federica Genovese |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2012-01-01
|
Series: | Biomarker Insights |
Online Access: | https://doi.org/10.4137/BMI.S10009 |
Similar Items
-
Molecular Serum Markers of Liver Fibrosis
by: Diana J. Leeming, et al.
Published: (2012-07-01) -
Serum Markers of Liver Fibrosis: Combining the BIPED Classification and the Neo-Epitope Approach in the Development of New Biomarkers
by: Sanne Skovgård Veidal, et al.
Published: (2010-01-01) -
Value of serum liver fibrosis markers in the diagnosis of liver fibrosis
by: ZHANG Yu
Published: (2019-11-01) -
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis <it>ex vivo</it> rat model
by: Veidal Sanne Skovgård, et al.
Published: (2012-12-01) -
Association of versican turnover with all-cause mortality in patients on haemodialysis.
by: Federica Genovese, et al.
Published: (2014-01-01)